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ABSTRACT 
 
 The La protein is an abundant RNA processing protein located in the nucleus of 
eukaryotic cells. Removal of the α-helical nuclear retention element domain in human 
La causes the inappropriate export of these hLa-ΔNRE mutants from the nucleus, 
resulting in the accumulation of non-functional aberrantly processed tRNAs within the 
cytoplasm. We hypothesized that the inappropriate nuclear export of hLa-ΔNRE may be 
an indirect consequence of altered RNA target binding in cells. Electrophoretic mobility 
shift assays revealed hLa-ΔNRE mutants exhibiting diminished binding affinity for 
precursor tRNAs in comparison to wild-type human La, however no differences in 
affinity were seen with poly A target binding. From this, we proposed a hypothetical 
model which suggests the cause for export of hLa-ΔNRE mutants is a result of 
competitive binding with mRNA targets in the nucleus. This competition for binding 
results in the inappropriate export of these mutants with mRNA targets in a crm1-
dependant manner. 
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INTRODUCTION 
The Lupus autoantigen commonly known as La is an abundant protein found in 
nearly all eukaryotes 1. La is a multidomain protein consisting of 408 amino acids, its 
domains are separated into a conserved N terminal region and a divergent C terminal 
region.  A human homologue of La was first identified as an autoantigen in patients 
suffering from autoimmune disorders lupus erythematosus and Sjogren’s syndrome 2 
giving rise to commonly used names Human La autoantigen (hLa) and Sjogrens 
syndrome antigen B (SS-B). La is an RNA processing protein found in all metazoans 
and its presence within higher eukaryotic organisms is essential for their viability 3. 
Deletions in fission yeast indicate the presence of La independent mechanisms which 
maintain their survival 4,5. The RNA processing activity of La is so highly conserved that 
human La can replace many processing functions of the fission yeast La protein known 
as Sla1p 8. This makes yeast a good study model to help understand La’s fundamental 
roles within the cell. 
 
1.1 La protein structure 
 The La protein is a member of a large group of RNA binding proteins that contain 
an RNA recognition motif (RRM) allowing it to bind various RNA substrates 6. The 
standard RRM follows a β1α1β2β3α2β4 topology in which four beta sheets are packed 
against two alpha helices allowing it to recognize single stranded RNA and engage in 
post transcriptional processes 9. La contains an RRM1 in its conserved N terminal 
region that slightly deviates from the standard topology possessing a αoβ1α1β2β3α2β4α3 
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architecture which includes the addition of an alpha helix (α0) at the beginning of the 
domain and an α3 helix located in La’s C-terminal region. Although slight variations in 
the secondary structural components that make up an RRM exist between different 
RNA binding proteins the method by which they interact with RNA is largely consistent. 
Single stranded RNA lying across the four beta sheets interacts with conserved 
aromatic side groups protruding from these sheets. Hydrophobic stacking interactions 
between the aromatic side groups and the targeted RNA allow for a stable contact 10.  
 
  
                                    “Standard” RRM                             hLa RRM1                                                                           
 
Figure 1: Structural representation of a standard RNA recognition motif (left) (PDB ID 1up1) 
and the first RNA recognition motif found in the NTD of the human lupus autoantigen (PDB ID 
1s79). Slight variations in the hLa RRM1 exist in comparison to a standard RRM. These 
differences include the presence of an α0 helix located near the NTD of hLa’s RRM1 as well as 
an additional α3 helix located near the C terminal region of the RRM1. Despite these 
differences, interaction with RNA targets is conserved and mediated through aromatic side 
chain residues protruding from the 4 beta-sheets depicted by the green residues in the standard 
RRM. Figure adapted from Clery et al 2004 9 and Alfano et al 2004 65.     
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 Along with the RRM1 domain, La also contains a La motif (LAM) which is critical 
in its binding of RNA substrates. The LAM consists of five alpha helices and three 
antiparallel beta sheets organized into a winged helix turn helix fold (wHTH) 11. This 
structure is commonly found in transcription factors which engage with dsDNA by 
inserting their recognition helix into the major groove. Other proteins bearing this wHTH 
fold such as the restriction endonuclease FokI use it for protein-protein interactions 12, 
this provides evidence for additional targets other than RNA that the La protein could 
potentially interact with. The LAM together with the RRM1 make up what is called the La 
module located in the conserved N terminal region of the protein. The binding pocket 
created by these domains is made possible through a short linker region that separates 
both domains 25. 
 
 
4 
 
 
 
Figure 2: Structural representation of the La motif seen from three separate angles (PDB ID 
1s29). The five alpha helices and three beta sheets the protein domain is comprised of are 
arranged in a winged Helix turn Helix orientation. Classically, this structural motif is known for 
interacting with double stranded nucleic acid sequences. The La Motif along with the RRM1 
collectively known as the La module form a binding pocket enabling La to interact with its 
various RNA substrates. This binding pocket is made possible due to a flexible linker region 
located between the two domains. Figure adapted from Dong et al. 2004 11. 
 
 
The C terminal region of La proteins is more divergent than the conserved N 
terminus and its size increases from yeast to higher organisms 25. The C terminal 
domain of human La contains the addition of a second RRM2 which is more commonly 
present in other higher eukaryotes. Immediately following the RRM2 is a region known 
as the Nuclear Retention Element (NRE) which has been demonstrated to form an α-
helical structure that partially blocks the β4 canonical RNA binding region of the RRM2 
(figure 3) 26. A short basic motif (SBM) which is only present in human La is located 
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directly after the NRE. This region is comprised of a Walker-A-like motif and has been 
shown to decrease hLa’s binding affinity for precursor tRNAs (pre-tRNAs) when the 
serine at position 366 is phosphorylated by casein kinase 2 (CK2) 28. A Nuclear 
localization signal (NLS) is located at the end of the C terminus in both yeast and 
human La. Since La has been known to shuttle between the nucleus and cytoplasm of 
cells depending on the RNA substrate it is bound to, 27 the NLS allows for La’s re-entry 
into the nucleus 29.  
 
 
 
Figure 3: Schematic diagram illustrating the protein domains that encompass the human lupus 
autoantigen (hLa) and its yeast homolog (Sla1p). The NTD region of both proteins are highly 
conserved with each containing both a La motif and an RRM1 motif. Structural divergence 
begins in the CTD region with hLa possessing and additional RNA recognition motif (RRM2) as 
well as a short basic motif (SBM). The alpha helical NRE region in hLa is also present directly 
after the RRM2 whereby its partially blocks access to the β4 sheet of the RRM2. In Sla1p this 
region immediately succeeds the RRM1. Figure adapted from Bayfield et al 2007 8. 
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1.2 La engages with a variety of RNA binding targets 
La preferentially binds to RNA targets ending in stretches of uridylate residues 
which occur on the ends of all nascent RNA polymerase III (pol III) transcripts 7. 
Recognition of the 3’ terminal UUU-OH by La is made possible through its interaction 
with the La module.  A crystal structure showcasing the recognition of the termini of 
nascent RNA Pol III transcripts by the La module specifies interaction of the final three 
uridylate nucleotides in a splayed apart orientation with the La module (figure 4) 6. Thus 
as designated in the cited paper, terminal uridylates U7 and U9 of the 9-mer RNA 
transcript fold together forming a C shape which allows recognition of U7 and U9 by 
conserved basic and aromatic residues in the La motif and recognition of U8 by the 
back bone peptides of β4 in the RRM1. The La motif contains the bulk of the 
responsibility for engaging in this poly uridylate binding mode since mutations 
incorporated into this domain abolish La’s recognition of poly uridylate sequences 22. 
The interaction between U8 and the RRM1 is interesting because it does not engage in 
any contact with the conserved basic residues of the RRM1 that were initially 
hypothesized for recognition. This leaves the unbound RRM1 region open to potential 
secondary contacts with the same or different RNA substrates. 
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Figure 4: A) A crystal structural of the La Motif (cyan) and the RRM1 (green) colllectively 
termed  the La module and their interaction with a  9mer RNA oligo (PDB ID 1zh5). The final 
three nucleotides of the 9mer comprised of uridines interact with the La module in a splayed 
apart orientation. The U8 nucleotide is critical for this interaction, by making hydrogen bond 
contacts with both I140 in the β5 sheet of the RRM1 and the amide group of G20 in the α1 helix 
of the LAM. In addition to this, U8 also interacts with tyrosine 23 of the α1 helix via ring stacking. 
The U9 nucelotide also makes ring stacking interactions with phenylalanines at positions 35 and 
55 on the LAM α2 and α3 helices respectively. The flexible linker region between both domains 
allowing for the formation of this binding pocket is highlighted in gray. Figure adapted form 
Teplova et al. 2006 6. B) RRM1 of human La with glutamic acid and aspartic acid residues at 
positions 132 and 133 respecitively along with phenylalanine at position 150 hilighted in green. 
Figure adapted from Bayfield et al. 2007 8.  
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La has been shown to interact with a variety of RNA Pol III transcripts such as 
pre-5S rRNA, Y-RNA and 7SK RNA however, its best characterized substrates are pre-
tRNAs 13-16. Binding to these pre-tRNA targets is dependent on the La modules 
recognition of the 3’ terminal oligo U tract along with secondary interactions made 
between loop 3 of the RRM1 and the tRNA body 22. The amount of terminal U’s present 
in the pre-tRNA 3’ trailer determines La’s binding efficiency, for example, human La 
requires a minimum of 3 terminal U’s for binding whereas yeast S. Pombe La require 4 
or more 7, 17-19. Preference for La to engage in pre-tRNA binding over poly U binding is 
dependent on UUU-OH independent interactions mediated by RRM1’s loop 3 region 
which is distinct from the La module binding site. Therefore, La’s poly U binding mode is 
required to recognize the 3’ trailer of pre-tRNAs and additional interactions made by the 
loop 3 of RRM1 stabilize this interaction and increase its affinity. Thus 3’ UUU-OH 
recognition by the La module in conjunction with RRM1 loop 3 interaction with pre-tRNA 
comprises La’s pre-tRNA binding mode.  
Recent unpublished data within our lab has shown that along with binding to 
nascent RNA pol III transcripts, La can also bind to poly A oligomers in a length 
dependent manner. This interaction is evident using an electrophoretic mobility shift 
assay (EMSA) also commonly referred to as a gel shift. The RNA substrate in question 
is radioactively labeled with 32P γ ATP which incorporates the labelled phosphate on the 
5’ end of the RNA during reverse transcription from cDNA. This radioactively labeled 
substrate becomes visible when exposed to a phosphor-screen and its migration in a 
gel is dependent on whether it binds to the protein it is placed with. Free labelled 
substrate that does not bind to the protein migrates to the bottom of the gel whereas 
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bound substrate migrates less creating a shift in the band appearance on the gel. The 
binding mode used to recognize poly A sequences involves the LAM, RRM1 and 
secondary RRM domain located at the C terminal region in human La known as RRM2. 
The particular regions within each domain and how each domain interacts with the poly 
A sequence are currently being investigated, however, it is presently understood that 
poly A binding occurs at separate sites on the LAM and RRM1 since mutations in the 
regions were poly U and pre-tRNAs interact with show no alteration of the poly A 
binding mode. Considering La’s extensive role in pre-cursor tRNA processing, research 
is ongoing to investigate whether La has regulatory functions in the processing of 
mRNAs, specifically binding to poly A tails and modulating the activity of poly A binding 
protein (PABP).   
 
1.3 Nuclear export of La’s RNA targets 
 As mentioned earlier, La can interact with a variety of RNA targets such as 
tRNAs, rRNAs, snRNAs as well as mRNAs primarily through the usage of its LAM, 
RRM1 and RRM2 binding domains. Although a commonality amongst these RNAs is 
that they can interact with La, they contain unique differences in their means of export 
from the nucleus, the general mechanisms of which will be briefly discussed. 
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1.3.1 mRNA export 
 There are two major export receptors of mRNA in mammalian cells; The Nuclear 
export factor 1 (Nxf1) and The Chromosome maintenance region 1 (crm1). Nuclear 
export via Nxf1 is accomplished by Nxf1 forming a heterodimer with NTF2-related 
export protein 1 (Nxt1) enabling the interaction with spliced mRNA via the enzyme 
complex TREX1 (conserved from yeast to humans) 46. This heterodimer interaction is 
critical since defective Nxf1 (which can not bind with Nxt1) does not promote mRNA 
export [47]. After passage of this messenger ribonucleoprotein (mRNP) through the 
nuclear pore complex (NPC) a conformational change in the mRNP known as 
“remodelling” occurs which is essential for mRNA dissociation in the cytoplasm and 
recycling of export factors back into the nucleus. The second major export factor Crm1, 
is a member of the importin-beta family. Crm1 itself is not an RNA binding protein, 
instead it requires an adaptor protein to accomplish this task. Crm1 interacts with the 
nuclear export signal (NES) of its cargo and export is mediated through Ran-GTP 48. To 
date, three crm1 adaptor proteins have been identified for the export of mRNAs; RNA 
binding protein Human antigen R (HuR), Leucine-rich pentatricopeptide repeat protein 
(LRPPRC) and nuclear export factor 3 (Nxf3). HuR interacts with messenger RNAs 
containing AU rich elements 49 while LRPPRC engages with mRNAs by directly 
interacting with eIF4E as well as 4E-SE RNA elements 50. Nxf3 possesses a Crm1 
dependant export signal and can tether mRNA for their export from the nucleus 51. In 
light of this, there still remain many RNAs exported by crm1 for which adaptor proteins 
have not yet been identified 52. 
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1.3.2 rRNA and snRNA export 
In addition to mRNAs, crm1 is also responsible for the nuclear export of rRNAs 
and snRNAs. Both the pre-60s ribosomal subunit containing 5s, 5.8s and 28s (25s in 
yeast) rRNA along with the pre-40s subunit containing 18s rRNA are exported in a 
crm1-dependant manner. Crm1 export of pre-60s ribosomal subunits are mediated 
through the adaptor protein Nmd3 whereas pre-40s subunits rely on interaction with 
adaptor proteins Ltv1 and Pno1/Dim2 for crm1 nuclear export 46. snRNAs are exported 
from the nucleus via crm1 through the aid of the PHAX adaptor protein which not only 
binds to crm1 but also the RNA’s cap binding complex (CBC) and the 5’ end of the 
snRNA 53. From this it is evident that crm1 is involved in the export of a variety of 
different RNA sequences with in the nucleus, however, the type of RNA exported via 
crm1 is dictated by the distinct adaptor protein with which they interact with. 
 
1.3.3 tRNA export 
Currently, the only well known exporter of tRNAs across the NPC is mediated 
through exportin-T (Xpot) in vertebrates and its homolog Los1 in yeast. Xpot/Los1 are 
members of the importin-beta family and like crm1, export is regulated by a Ran 
GTPase. At the present time, Los1 is the only protein known to transport intron-
containing pre-tRNAs into the cytoplasm 54 however, the yeast Los1Δ strain is viable. In 
addition to this, the Arabidopsis thaliana plant Xpot homolog PAUSED is non-essential 
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and insects lack a Xpot homolog 55-59. Taken together, these data suggest the existence 
of a novel nuclear exporter for tRNAs. After their transcription and export, tRNAs can 
contribute to translation in the cytoplasm however, it has been recently determined that 
tRNAs can undergo retrograde import into the nucleus and that this process is 
conserved from yeast to humans 60-62. The biological function of this retrograde import is 
speculated for additional tRNA modification or tRNA quality control purposes 63,64.   
 
1.4 La’s role in the processing and maturation of precursor tRNAs 
La promotes the proper processing of pre-tRNAs to mature tRNAs via a 
mechanism known as simple 3’ end binding. La begins the process by binding to the 3’ 
terminal oligo U tract of pre-tRNAs protecting them from degradation of 3’ exonuclease 
Rex1p 20, 21. The number of uridylate residues at the 3’ terminus defines La’s binding 
affinity to the pre-tRNA which in turn dictates whether processing is completed via a La-
dependant or La-independent manner (Figure 4). In addition to this 3’ end binding, the 
loop 3 region (amino acids 143-151) of hLa’s RRM1 also binds to the body of the pre-
tRNA and stabilizes this interaction. Collectively these site separate binding events 
comprise the pre-tRNA binding mode. La directs the removal of the 5’ leader sequence 
of pre-tRNAs by RNase P to precede 3’ trailer processing since in the absence of La 
this order is reversed in yeast 16.  The 3’ end protected pre-tRNA then becomes 
processed by RNaseZ precisely at the first unpaired nucleotide following the acceptor 
stem leading to the dissociation of La from the tRNA and the addition of CCA 
trinucleotide to the new 3’ end 22. Additional chemical modifications to the tRNA are 
13 
 
 
made during this period prior to its export into the cytoplasm via Los1 in yeast or 
exportin-t in vertebrates. About 20 percent of all pre-tRNAs contain an intron, and if 
present, splicing occurs once the precursor tRNA has been exported into the cytoplasm 
where the pre-tRNA splicing machinery is located on the outer membrane of the 
mitochondria. La dissociates from the 3’ trailer in the nucleus and recycles to re-
associate with a new pre-tRNA facilitating their maturation 25. Since La uses two sites 
(LAM and RRM1) to produce high affinity binding of pre-tRNA, binding with one site 
alone results in lower target affinity and lower stability. Therefore, once a 3’ trailer is 
cleaved La interacts with the mature tRNA and the 3’trailer both with lower affinity 
causing it to dissociate and recycle onto a new pre-tRNA whereby both of its binding 
sites can be utilized simultaneously 22. As mentioned previously La is not essential to 
ensure viability in yeast, therefore a La-independent mechanism is present allowing for 
the proper processing of pre-tRNA. In the absence of La, the 3’ trailer which is normally 
protected from 3’ exonucleases is processed first by Rex1p. If the pre-tRNA contains 
the proper folding and is deemed functional by surveillance mechanisms within the 
nucleus, RNase P then removes the 5’ leader and it is exported into the cytoplasm. 
Unfortunately, in this La-independent pathway, if the pre-tRNA is structurally impaired it 
becomes targeted for degradation by 3’ exonucleases 25. Interestingly, when La is 
overexpressed in yeast it is able to rescue misfolded and structurally impaired pre-
tRNAs and allows for their processing and maturation into functional tRNAs 5. 
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Figure 5: La-dependant and La-independent pathways for pre-tRNA processing and 
maturation. The processing of pre-tRNAs can take one of four pathways. Normal and defective 
pre-tRNAs processed in a La-dependant manner (seen in the middle pathway) first have their 5’ 
leader sequence cleaved by RNAse P followed by elimination of their 3’ uridylate trailer by 
RNase Z. In the absence of La, the order of this processing is reversed with normal pre-tRNAs. 
(rightmost pathway) however, a functionally mature tRNA is still created. In contrary, defective 
pre-tRNAs can not be processed into a functional mature tRNA in the absence of La (pathway 
on the left) and therefore, are targeted for degradation by 3’ exonucleases. Defective pre-
tRNAs, when processed in a La-dependant manner result in functional mature tRNAs that can 
participate in protein translation. This highlights the importance of La’s presence; it ensures 
initially defective pre-tRNAs are correctly processed to form functional tRNAs. Figure adapted 
from Bayfield et al. 2010 25. 
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To further investigate La’s role in tRNA processing, yeast strains containing a 
mutation that disrupts the secondary structure of essential tRNAs from forming were 
shown to be non-viable upon deletion of La 16, 23.  These structurally impaired pre-tRNAs 
were more susceptible to degradation from surveillance activities of the TRAMP 
polyadenylation complex which polyadenylates aberrantly formed RNAs targeting them 
to the nuclear exosome Rrp6 for removal. Furthermore, the absence of proper tRNA 
modifications can sensitize certain pre-tRNAs to degradation by the nuclear surveillance 
system. For example, in the case of pre-tRNAi Met, failure to be methylated on adenine 
58 by the tRNA methyltransferase TRM61 leads to the nuclear degradation of the 
hypomodified pre-tRNA. Overexpression of La can prevent the degradation of this pre-
tRNA and permit the mature hypomodified tRNAi Met to be exported into the cytoplasm 
where it functions appropriately in translation 24. Such findings indicate a more complex 
mechanism is present in conjunction with the simple 3’ end binding which enables La to 
rescue structurally impaired precursor tRNAs and hypomodified pre-tRNAs that would 
normally be targeted for destruction. The RNA binding domain responsible for this RNA 
chaperone activity has been localized to the RRM1 of human and S. Pombe La proteins 
20, 22. 
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1.5 La Related Proteins: LARPs  
 La related proteins commonly referred to as LARPs are a collection of proteins 
which contain a conserved 90 amino acid signature La motif similar to that of the 
genuine La protein 33. Humans carry five LARP subfamilies; LARP1 with variants 1a and 
1b, LARP3, LARP 4 with variants 4a and 4b, LARP6 and LARP7. The genuine La 
protein has recently been termed as LARP3 by the HUGO gene classification system, 
but will continually be referred to as La or genuine La protein for the duration of this 
thesis. 
 Although two variants of LARP1 exist and contain about 60% homology with one 
another, all published work to date has been completed on the more abundantly 
processed LARP1a which provides a stronger knockdown phenotype 34. Unlike genuine 
La protein which is normally located in the nucleus, LARP1 is predominantly 
cytoplasmic. LARP1 was the first of the LARP family shown to bind with PABP in an 
RNA-independent manner 35. Knockdown of LARP1 is associated with a 15% reduction 
in overall protein synthesis and an increase in hypophosphorylated 4E-BP1, implying its 
involvement with cap-mediated mRNA translation 34. Despite all of this, LARP1 contains 
all of the conserved amino acids with in its La motif required for 3’ UUU-OH recognition.   
To date there are two known paralogues of LARP4 identified as LARP4a and 
LARP4b. These LARP4 variants are the most divergent subfamily of LARPs from the 
genuine La protein. They lack key aromatic and basic side chain residues with in the La 
motif required from 3’ terminal uridylate sequence recognition suggesting that they may 
have distinct RNA targets they engage with 25. LARP4a is found with in the cytoplasm of 
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cells where it stimulates mRNA translation in part through the scaffold protein 
Ribosome-associated receptor for activated C kinase (RACK1) with cytosolic PABP and 
mRNAs via their polyadenylate tails 36. LARP4b, previously termed as LARP5 only 
shares 34% homology overall with LARP4a but 74% homology between their La 
modules. LARP4b is predominantly found in the cytoplasm where it has been shown to 
stimulate translation and co-sediment with the 40s ribosome component either directly, 
or through its interaction with RACK1 37. 
 LARP6 contains a conserved La module that can recognize 3’ UUU-OH 
sequences as well as a uniquely conserved SUZ-C motif at it’s C terminus believed to 
contribute to mRNA substrate recognition 38. Mammalian LARP6 has been shown to 
interact with developmental transcription factor Cask-C 39,40 and functions upstream of 
transcription factor MyoD to control muscle development 39,40,41. In addition to a 
transcription factor-associated protein LARP6 has been shown to specifically bind to a 
conserved stem-loop motif in the 5’UTR of α1 collagen mRNAs 42. Thus, LARP6 
shuttles between the nucleus and cytoplasm while participating in the nuclear export of 
collagen mRNAs 43. 
LARP7 is an RNA binding protein with high homology to the genuine La protein 
in it’s La module however, it does contain a divergent c-terminal domain. Like the 
genuine La protein, LARP7 binds to pol III transcripts but replaces La protein by 
specifically recognizing the 3’ UUU-OH of a single RNA pol III transcript the 7SK snRNA 
44. 7SK snRNA is an abundant non-coding RNA that regulates mRNA metabolism by 
controlling the activity of the positive transcription elongation factor b (P-TEFb) 45 a 
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kinase required for RNA pol II transcription elongation. Because of this, like genuine La 
protein, LARP7 primarily resides in the nucleus of cells. 
 
1.6 La’s NRE can modulate its intracellular localization 
 The Nuclear retention element located in La’s divergent C terminal domain is 
found between amino acids 316-332.This region has been shown to play an important 
role in controlling La’s intracellular localization. Studies have shown that La without its 
NRE (ΔNRE mutants) clearly illustrates cytoplasmic localization compared to wild-type 
La which remains almost entirely nuclear (Figure 6) 30. To clarify whether removal of the 
NRE causes inappropriate export from the nucleus or non-functional import into the 
nucleus, cells expressing hLa-ΔNRE were treated with leptomycin-B (LMB). LMB is 
responsible for blocking CRM1 mediated export from the nucleus. Therefore, RNAs 
recognized by hLa for proper processing and CRM1 for export, would be denied access 
out of the nucleus 31, 13. Blocking CRM1 export resulted in substantial restoration of 
ΔNRE mutants into the nucleus confirming that the absence of the NRE results in the 
inappropriate export of La. This is distinct from La mutants which have their NLS 
deleted (hLa 1-375). Although these mutants contain a cytoplasmic phenotype, LMB 
treatment has no restorative effect indicating the non-functional import of these mutants 
into the nucleus.  Furthermore, yeast expressing ΔNRE mutants show an accumulation 
of aberrantly processed tRNAs. Due to the inappropriate export of ΔNRE mutants into 
the cytoplasm, the tRNAs associated with them do not have their 5’ leader or 3’trailer 
removed thus resulting in spliced tRNAs with unprocessed ends 30. These aberrantly 
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processed tRNAs have lost their functionality required for protein translation 8. LMB 
treatment restored the proper pre-tRNA processing in yeast containing ΔNRE mutants 
therefore concluding that the NRE is not responsible in La’s pre-tRNA processing 
activities, instead, its presence is simply required to keep La nuclear in order for the 
proper processing of 5’ and 3’ ends to occur. Attempts to decipher the determinants 
within the NRE that cause its cytoplasmic phenotype lead to the discovery of two 
conserved lysine residue found at positions 316 and 317 in La. Mutations made to these 
lysine residues converting them into alanine (KK mutants) resulted in the same 
inappropriate export that was seen with the ΔNRE mutants. These KK mutants also 
generated aberrantly processed non-functional tRNAs 8 indicating the importance of 
lysine residues 316 and 317 in controlling NRE’s intracellular trafficking of La. 
Interestingly, compensatory mutations made to the RRM1 of ΔNRE mutants restore 
nuclear localization and pre-tRNA processing, these double mutants include: ΔNRE 
E132A D133A and ΔNRE F150A.  
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Figure 6: Intracellular localization of GFP tagged hLa (right) and GFP tagged hLa-ΔNRE. Under 
normal conditions, fluorescence emittance from the tagged protein shows that hLa is nuclear (E) 
while hLa-ΔNRE mutants are exported to the cytoplasm (H). Blocking all crm1 mediated export 
from the nucleus through treatment of cels with leptomycin b (LMB) results in nuclear 
accumulation of hLa-ΔNRE mutants (N). LMB treatment on cells expressing GFP-hLa yields no 
change in intracellular localization. Adapted from Intine et al. 2002 30. 
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1.7 Thesis Proposal 
 To date, no model or regarded mechanism has been generated to explain the 
cytoplasmic phenotype associated with hLa-ΔNRE mutants. This thesis will attempt to 
improve our understanding into what makes hLa’s NRE so important for maintaining its 
nuclear phenotype and why the protein becomes cytoplasmic when its mutated or 
removed. Based on the complexity of hLa’s RNA binding modes and the variety of RNA 
targets it binds to, we hypothesized that the inappropriate nuclear export of hLa- ΔNRE 
may be an indirect consequence of altered RNA target binding in cells. More 
specifically, we hypothesize that the NRE is important for maintaining hLa’s appropriate 
conformation for binding precursor tRNAs substrates in the nucleus; with its removal 
making the protein more vulnerable to binding less favoured RNA substrates. This 
defect in RNA substrate specificity could make ΔNRE mutants more vulnerable to 
inappropriate export from the nucleus.  
To investigate target RNA binding differences, EMSAs were used to compare the 
interaction between hLa and ΔNRE mutants with U10 and A20 RNA oligomers as well 
as with CGC alanine pre-tRNA substrates. The U10 oligomer was used to examine any 
affinity differences in La’s 3’ terminal uridylate binding mode whereas the A20 oligo was 
selected to identify any differences in the protein’s poly A binding mode. Furthermore, 
CGC ala pre-tRNA was used to examine any differences in binding affinity with La’s 
most characterized binding substrate: precursor tRNAs. ΔNRE mutants containing 
additional compensatory mutations in the RRM1 domain (E132A D133A or F150A) that 
were shown to restore nuclear localization [8] were also tested against the same RNA 
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substrates to pinpoint any binding similarities shared with hLa that could explain their 
similar cellular localization phenotypes.  In addition to this, recent unpublished 
hydrogen-deuterium exchange (H/D exchange) mass spectrometry data from a 
collaborating lab has emerged identifying a potential inter-protein domain salt bridge 
interaction. The glutamate and aspartate residues at positions 132 and 133 in La’s 
RRM1 and the lysine residues at 316 317 in the NRE could be critical in La’s ability to 
discriminate between various RNA targets. We decided to take advantage of the ΔNRE 
mimicking phenotype of the previously mentioned “KK mutant” with a slight alteration. 
Instead of inserting alanine residues at positions 316 and 317 to disrupt this proposed 
salt bridge interaction, negatively charged glutamic acid residues were used. 
Substitution with glutamate residues instead of alanine allows us to potentially restore 
this salt bridge (and hopefully wildtype hLa activity) by inserting lysine residues at 
positions 132 and 133 creating a hLa E132K D133K K316E K317E mutant. This 
mutant’s interaction with the aforementioned RNA substrates was also examined using 
EMSAs. 
Next, we wanted to examine how hLa, hLa-ΔNRE and the various point mutants 
behaved when simultaneously presented with the opportunity to bind two different RNA 
targets. Thus, competition EMSA analysis were conducted to investigate this. A 
constant amount of radioactively labelled pre-tRNA was incubated with increasing 
amounts of cold (non-radioactive) A20 oligomer to see whether this increase in cold A20 
would sufficiently compete off pre-tRNAs for binding. Identifying how hLa, ΔNRE and 
point mutants behave upon simultaneous exposure to multiple RNA targets may 
uncover a mechanism by which to explain La’s cellular localization phenotype. 
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Finally, we sought to identify the relative proportion of tRNA and mRNA 
sequences interacting with hLa and hLa-ΔNRE in vivo. Being strictly nuclear, and 
involved with pretRNA processing, it was proposed that hLa would bind to a greater 
proportion of tRNAs in comparison with mRNA targets. Conversely, it was hypothesized 
that ΔNRE mutants might interact more so with mRNA targets due to its cytoplasmic 
phenotype and lower affinity pre-tRNA binding. To check for this, Hek 293T cells were 
transfected with GFP tagged hLa and ΔNRE mutants. The RNA targets interacting with 
these proteins where pulled down using cross-linking immunoprecipitation (CLIP) and 
subsequently subjected to northern blot analysis using probes that recognize 
methionine tRNA and Poly A sequences. Quantification of these northern blots would 
enable us to calculate a ratio of tRNA to mRNA sequences immunoprecipitated with hLa 
and the cytoplasmic hLa-ΔNRE mutant. The goal from this is to then see if these results 
support the RNA target binding affinities obtained from the in vitro EMSA data.    
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MATERIALS AND METHODS 
 
2.1 Site directed Mutagenesis 
 
 To create the hLa-ΔNRE double mutant ΔNRE E132A D133A, the salt bridge 
disrupting hLa K316E K317E mutant and the salt bridge restoring hLa E132K D133K 
K316E K317E mutant site directed mutagenesis was conducted. The forward and 
reverse oligo primers (IDT Technologies) containing the appropriate point mutations to 
create the desired amino acid conversions for each protein are summarized in Table 1. 
  
Table 1: Primer sequences used for site directed mutagensis of hLa pet28A and hLa-
ΔNRE pet28A vectors. 
Primer name Primer sequence 
hLa E132A D133A For 5’-ACTCTTGATGACATAAAAGAATGGTTAGCAGCTAAAG 
GTCAAGTACTAAATATTCAGATG-3’ 
 
hLa E132A D133A Rev 5’-CATCTGAATATTTAGTACTTGACCTTTAGCTGCTAACCATT 
CTTTTATGTCATCAAGAGT-3’ 
 
hLa E132K D133K For 5’-
CTCTTGATGACATAAAAGAATGGTTAAAAAAGAAAGGTCAAGTACT 
AAATATTCAGATG-3’ 
 
hLa E132K D133K Rev 5’-
CATCTGAATATTTAGTACTTGACCTTTCTTTTTTAACCATTCT 
TTTATGTCATCAAGAG-3’ 
 
hLa K316E K317E For 5’-GAAGGAGAGGTGGAAAAAGAAGCACTGGAGGAAAT 
AATAGAAGACCAACAAGAATCCC-3’ 
 
hLa K316E K317E Rev 5’-GGGATTCTTGTTGGTCTTCTATTATTTCCTCCAGTGCT 
TCTTTTTCCACCTCTCCTTC-3’ 
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The forward and reverse primers for E132A D133A, K316E K317E and E132K and 
D133K were diluted to create a 200µM stocks. The “Quick-change” procedure used to 
perform the site directed mutagenesis was performed in a 50µL reaction summarized in 
table 2.  
 
Table 2: PCR setup used for site directed mutagenesis of hLa pet28A and hLa-ΔNRE 
pet28A vectors. 
COMPONENTS FINAL CONCENTRATION VOLUME (µL) 
5x Reaction Buffer 1X 10 
10mM dNTPs 0.2mM 1 
20µM Forward Primer 0.5µM 1.25 
20µM Reverse Primer 0.5µM 1.25 
Mini-Prepped DNA 0.5-0.7µM 1 
Phusion Enzyme 1 unit/50µL PCR reaction 1 
RNase Free water  35 
Total  50 
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Table 3: PCR cycle settings for site directed mutagenesis of hLa pet28A and hLa-
ΔNRE pet28A vectors. 
CYCLE STEP TEMPERATURE DURATION NUMBER OF 
CYCLES 
Lid 105°C   
Initial Denaturation 98°C 6 min 1 
Denaturing 98°C 30 sec  
20 Primer Annealing 50°C 30 sec 
Extension 72°C 16 min 
Final Extension 72°C 16 min 1 
Hold 4°C   
 
The 6 hour procedure was then held at 4 oC overnight. Reaction samples were then 
treated with 1µL of Dpn I (N.E Biolabs cat #: R0176S) and placed in the 37oC water 
bath for 1 hour to eliminate the methylated parental vector. The Dpn I treated samples 
were then placed in 65oC water bath for 15 minutes to denature the Dpn I enzyme. 
 
2.1.1 Transformation of double mutants into E.Coli XL-1 strain 
The hLa and ΔNRE pet28A plasmids mutated via site directed mutagenesis were 
transformed into Escherichia Coli XL-1 gold strain and plated on kanamycin plates to 
check for bacterial colony formation. As a positive control to ensure that hLa and ΔNRE 
pet28A mini-preps yielded enough template required for mutagenesis, these non-
mutated mini-preps were also transformed into XL-1 to check for colony formation. The 
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bacterial transformations were performed as follows; 4µL of quick-change product was 
added to 50µL of thawed XL-1 gold cells in a pre-chilled microfuge tube and left to 
incubate on ice for 20 minutes. For mini-prepped samples, 1µL of ΔNRE pet28A vector 
(26.4ng) and hLa pet28A vector (34.6ng) were added to 25µL of XL-1 gold cells and 
incubated on ice for 20 minutes. Samples were heat shocked in a 37oC water bath for 
90 seconds to allow the vector DNA to enter bacterial cells. After heat shocking, 
samples were placed on ice for 2 minutes. Addition of LB media to the heat shocked 
samples was performed by a bunsen burner flame to ensure a sterile setting. For 
mutated hLa and ΔNRE vectors 400µL of media was added while mini-prepped 
samples containing fewer cells (25µL) were given 200µL of media. Samples were 
placed in a 37oC water bath to incubate for 70 minutes. Because the pet28A vector 
contains kanamycin resistance, plating on LB kanamycin plates acts as a selection 
method for growth of only XL-1 cells transformed with the appropriate hLa or ΔNRE 
pet28A vector. Plating was performed in a sterile setting using a bunsen burner, the 
entire quantity of the samples (225µL of transformed cells containing the mini-prepped 
vector and 450µL containing the mutated vector) were added to the plate. To ensure 
even distribution of the XL-1 cells within the plate, 10-15 sterile beads were added and 
shaken inside the plate. Beads were discarded, and the plates were placed upside 
down in the 37oC incubator overnight. Colonies formed on the plates containing the 
transformed hLa and ΔNRE mutants were picked and added to round bottom conical 
tubes containing 5mL of LB media and 25µL of kanamycin (10mg/mL) in the presence 
of a flame. These cultures were grown overnight in a 37oC shaker (Eppendorf innova 
40) at 200 RPM. 
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2.1.2 Mini-prep of Escherichia coli XL-1 strains 
 Overnight XL-1 bacterial cultures transformed with mutated variants of hLa and 
ΔNRE pet28A vectors were mini-prepped in order to obtain DNA. The Omega Bio-Tek 
E.Z.N.A plasmid mini DNA kit I quick guide centrifugation protocol was used to perform 
all mini preps completed in this thesis. The presence of E132A D133A point mutations 
in the ΔNRE pet28A vector along with the E132K D133K and K316E K317E point 
mutations in hLa pet28A were confirmed through sequencing services provided by the 
Hospital for Sick Children (TCAG sequencing Facility).  
 
 
2.2 Protein Expression and Purification 
      
2.2.1 LB Media Preparation 
 
 In order to support bacterial cells growth and expression of protein, 1 LB cultures 
were prepared with the following recipe: 10g NaCl (Multipharm cat #: K35163700 539), 
10g Peptone (Fisher Scientific cat #: 73049-73-7) and 5g of yeast extract (Bioshop cat 
#: 8013-01-2). After thorough mixing with a magnetic stirring rod at 1000RPM for 5 
minutes, media was autoclaved.  
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2.2.2 Seeding LB Culture and Protein Induction 
 Two overnight cultures were seeded into 1L of LB media that was pre-heated in a 
37oC shaker (Eppendorf innova 43) for 15 minutes. To prevent contamination, 5mL of 
kanamycin was added for a final concentration of 0.05mg/mL. After seeding down, the 
1L cultures were left to grow for 3 hours at 37oC at 200RPM until an O.D 600 reading of 
0.6-1.0 (mid-log) was achieved. Using proper sterile technique, 1mM of IPTG (Fisher 
Scientific cat #: 367-93-1) was added to the 1L cultures to induce protein expression for 
3 hours. After 3 hours of protein induction, the 1L cultures were transferred to 1mL 
Beckman centrifuge bottles. Cells were pelleted at 6000 RPM for 15 minutes at 4oC 
using the Beckman Avanti J 9.1 rotor. The supernatant was removed and the pellet was 
re-suspended into a 50mL conical tube using of a pellet transferring buffer consisting of 
2.5mL of 1M Tris pH 7.4 and 0.29g NaCl in 50mL of dH20. The broth was then spun in a 
centrifuge (Eppendorf 5430R) using a F-35-6-30 rotor at 6000 RPM for 15 minutes at 
4oC. The supernatant was removed, and the pelleted cells were stored in a -80oC 
freezer.  
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2.2.3 Protein Purification Using His-trap Columns 
  
 Recombinant proteins containing a 6x His-tag on their C-terminal domain were 
purified using Ni2+ affinity chromatography. Cell pellets stored from protein induction 
were thawed on ice and re-suspended in 10 mL of lysis/binding buffer (50mM Tris HCl 
pH 7.6, 500mM NaCl, 0.05% Igepal, 20mM Imidazole, 5mM β-mercaptoethanol). 
Following re-suspension, 100μL of protease inhibitor cocktail (Sigma Cat #: P8849) was 
added. To disrupt the cell membranes, cells were sonicated (Misonix XL-2000 series) in 
pulses lasting 15 seconds at 0.05W followed by a 15 second break period for a total of 
12 minutes. The sonicated samples were spun at max speed for 30 minutes at 4°C in 
the Eppendorf 5430R centrifuge, and the supernatant was transferred into a 15mL 
conical tube. To ensure elimination of all cellular debris, a second spin at max speed for 
20 minutes at 4°C was completed and the supernatant transferred to a new 15mL 
conical tube. For purification, a separate 1mL Ni2+ His-trap FF column (GE Healthcare 
Cat #: 17-5319-01) was used for each protein. Columns were first washed with 5mL of 
ddH2O followed by 5mL of lysis binding buffer to equilibrate the columns. Next, 10mL of 
lysate was added to the column using a sterile 15mL syringe. The flow-through was 
collected in a 15mL conical tube and stored for SDS-PAGE analysis. Columns were 
then washed 3 times with 5mL of wash buffer (50mM Tris HCl pH 7.6, 500mM NaCl, 
20mM Imidazole, 1mM β-mercaptoethanol) with each wash collected in a separate 
15mL conical tube for SDS-Page. Finally, 5mL of elution buffer (50mM Tris HCl pH 7.6, 
500mM NaCl, 300mM Imidazole, 5mM β-mercaptoethanol,1 mM EDTA) was ran 
through the column and collected into a 15mL conical tube. 
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2.2.4 Protein Cleaning Using HiTrap Heparin HP Columns 
 Heparin columns were used to eliminate any residual nucleic acids that may still 
be bound to the protein after purification. The 5mL protein elution obtained from the final 
step of the His-trap purification was loaded into a 1mL HiTrap Heparin HP column (GE 
Healthcare Cat #: 17-0406-01) using a sterile 15mL syringe. The flow-through was 
collected in a 15mL conical tube and stored for SDS-Page analysis. Heparin columns 
were then washed with 5mL of 1X EMSA buffer (20mM Tris-HCl PH 7.6, 100mM KCl, 
0.2mM EDTA, 1mM DTT) and collected into a 15mL conical tube. Subsequent 5mL 
washes were conducted using 1X EMSA buffer containing increasing amounts of KCl to 
displace the protein off the column. These washes consisted of final KCl concentrations 
of 200mM, 400mM, 800mM, 1.2M and 2M. All washes were collected in 15mL conical 
tubes for SDS-page. After KCl washes, columns were rinsed with 10mL of ddH2O 
followed by 5mL of 20% ethanol and stored at 4oC. The 800mM KCl washes were then 
desalted to remove excess imidazole and KCl present in the buffer. A 1:1 ratio of protein 
elution and chaperone buffer (50mM Tris HCl pH 7.6, 1mM DTT, 1.5mM MgCl2) were 
added to 5mL concentrator tubes (Amicon Ultra, 10 kDa) and spun at 5000 RPM for 40 
minutes at 4°C. Flow through from the concentrator column was discarded and 
additional chaperone buffer was added for a final volume of 4 mL. The samples were 
spun down to a final volume of 100-150μL as indicated by the scale on the concentrator 
column. Glycerol was added for a final concentration of 5% and samples were stored at 
-80oC. 
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2.3 RNA labelling with 32P ATP 
 
2.3.1 A20, U20 and U10 Labelling with γ-32P ATP 
 
 To label the 5’end of RNA, T4 polynucleotide kinase (PNK) was used to transfer 
the γ-32P of the ATP (PerkinElmer) to the 5’ end of the A20, U20 and U10 oligos (IDT). 
The labelling reaction for each substrate was completed in a 20μL final volume using 
the following setup: 2μL of 20μM oligo RNA, 2μL of γ-32ATP (activity of 3000Ci/mmol), 
2μL of 10X T4 PNK buffer, 1μL T4 PNK, 13μL RNase free H2O. The samples were 
incubated at 37°C for 2 hours to allow for sufficient labelling of the RNA oligos.  
     
2.3.2 Labelling CGC precursor tRNA with α-32P ATP 
  
 CGC alanine pre-tRNA was radioactively labelled with α-32P ATP using an Sp6 
promoter transcription Kit (Ambion MEGAscript SP6 Cat#: AM 1330). This ATP with a 
radioactively labelled phosphate at the α position becomes incorporated into the pre-
tRNA sequence during transcription making it radioactive. The Sp6 reaction was 
completed in a 20µL final volume with the following setup: 2µL of 75mM CTP, UTP and 
GTP. 2µL of 0.75mM ATP, 2µL of reaction buffer, 125nM of CGC pre-tRNA template, 
2µL of α-32P ATP (activity of 3000Ci/mmol), 2µL Sp6 polymerase and 4µL of DNase 
RNase free H2O. The sample was then placed at 37oC overnight.  
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2.3.3 Gel Extraction of 32P Labelled RNA 
After RNA labelling, 5μL of formamide dye (80% deionized formamide, 10 mM 
EDTA, 0.06% bromophenol blue, 0.06% xylene cyanol) was added and samples were 
heated at 95°C for 8 minutes. The A20, U20 and U10 samples were then loaded on a 
15% denaturing urea gel whereas CGC pre-tRNA samples were loaded onto a 10% 
urea gel (1X TBE, 15% or 10% polyacrylamide, 7M urea, 0.08% APS, 0.037% TEMED). 
Gels were run at 100V at 4°C with 1X TBE as the running buffer until the bromophenol 
blue dye reached ¾ the length of the gel. The gel plates were opened and the exposed 
side was placed facing upwards in a cassette. Plastic wrap was used to cover the 
exposed side and Glogos ® II Autoradmarkers (Agilent technologies Cat#: 420201) 
were placed on each side of the gel as markers for band location. In a dark room, 
HyBlot CL Autoradiography film (Denville Scientifc Cat#: E3012) was placed on the gel 
for a 2 minutes. Films were developed showing the location of the radioactive bands 
within the gel. Using the developed film as a guide, the radioactive bands were 
extracted using a razor and placed in a 0.5 mL microfuge tube with the bottom of the 
tube cut off. This microfuge tube was placed in a 1.5mL microfuge tube and spun down 
for 1 minute at 14 000 RPM (Eppendorf 5415C) to shred the extracted gel into small 
pieces. The resulting pieces were then immersed in 250μL of 0.5M NaCl overnight to 
elute the RNA. A scintillation counter (Hidex 300SL) was used to determine the activity 
in CPM of the radioactive RNA (1μL of RNA in 7mL of scintillation fluid). 
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2.4 Electrophoretic mobility shift assay (EMSA)  
 
To assess protein interaction with the various RNA substrates, 
electrophoretic mobility shift assays were conducted. 10X EMSA buffer (200mM Tris 
HCl pH 7.6, 50mM B-mercaptoethanol, 1M KCl, 10mM EDTA) was prepared for 
inclusion into master mix and for creation of the protein (La) dilution buffer. La dilution 
buffer (LDB) (1X EMSA, 10% glycerol in 200µL final volume) was used to dilute proteins 
varying from 0 – 8000nM.  The exact amounts of buffers and radioactively labelled RNA 
added into the master mix was dependant on the number of lanes (1 gel = 10 lanes, 3 
gels = 30 lanes etc;).  The master mixes were set up as follows: 1X EMSA buffer/Lane, 
10% glycerol/Lane, labeled RNA with an activity of 3000 cpm/lane, 10µL of 
bromophenol blue dye (diluted in RNase free water), and RNase free water for a final 
volume of 20µL multiplied by the number of lanes prepared. The master mixes were 
heated at 95°C for 4 minutes and then slow cooled back to room temperature. 2μL of 
protein diluted to 10X the required amount of was added to 18μL of master mix to create 
1X final concentrations varying from 25-8000nM. A reaction with no protein (2μL of LDB 
buffer with 18μL of master mix) was used as a control lane representing 0nM of protein 
present. The reaction mixes were incubated at 37°C for 20 minutes, and then placed on 
ice for 5 minutes. A 6% native gel (1X TBE, 6% polyacrylamide, 0.08% APS, 0.037% 
TEMED) was pre-run for 15 minutes at 4°C with 1X TBE buffer. Samples were loaded 
and the gel was run at 100V at 4°C until the bromophenol blue dye ran ¾ of the way 
down the gel (for A20, U20 and U10) and entirely off the gel for CGC pre-tRNA. The gel 
was removed from the glass plates, placed on whatman filter paper (GE healthcare Cat 
35 
 
 
#: 3001-917) and then placed in a gel dryer (BioRad model 583) for 40 minutes at 80°C. 
Once the gels were dried, they were placed in an autoradiography cassette and left to 
expose on a storage phosphor-screen overnight. The screen was then scanned using a 
phosphor-imager (GE typhoon scanner) to visualize the radioactive protein-RNA 
complexes on the gel. The bands were quantified using the Image Quant TL software. 
These quantifications were implemented into Graphpad prism software to generate 
binding curves.  
 
2.4.1 Competition EMSA 
 Identical setup as a standard EMSA with the following modifications. 1.) A 
Constant amount of protein (2µM final) used in each lane rather then an increase in 
concentration. 2.) 10X stocks of cold competitor RNA were made (5, 20,80 and 320µM) 
3.) Reactions were setup in the following order; 16µL of master mix added first followed 
by 2µL of a 10X cold competitor RNA and 2µL of 10X protein stock to create a 1X final. 
Samples were then incubated at 37°C for 20 minutes whereby the standard EMSA 
protocol was used to complete the experiment. 
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2.5 Cross-linking Immunoprecipitation (CLIP) assay 
2.5.1 Transfection of Hek 293T cells  
To obtain a sufficient yield of Hek 293T cells for downstream experimental 
applications, two 15cm dishes of cells were used per vector resulting in eight 15cm 
dishes for the 4 different expression vectors. These eight 15cm dishes containing Hek 
293T cells at 75% confluency were transfected with either 15µg of GFP-tagged hLa, 
ΔNRE, 1-375 or c-myc-tagged PABP. This was completed by adding 15µg of vector 
DNA with 1.5mL of opti-MEM media (Gibco Cat #:31985-070) in one set of 15mL 
conical tubes and 40µL of lipofectamine 2000 (Life technologies Cat #:11668-027) with 
1.5mL of opti-MEM media into a second set of 15mL conical tubes. After a 5-minute 
incubation, contents from the first set of conical tubes were added to the second set 
containing the lipofectamine 2000 and incubated together for 15-minutes at room 
temperature. During this incubation, Hek 293T cells were washed once with 10mL of 
PBS (Multicell Cat #: 311-010) and refed with 12mL of fresh 10% FBS DMEM (Gibco 
Cat #:11965-092) media without antibiotics. The 3mL opti-MEM solution containing 
vector-lipofectamine complexes were added to the 15 cm dishes and left to incubate for 
6 hours to allow for transfection of vector DNA into cells. After incubation, cells were 
refed with fresh media containing 2% Pen Strep (Gibco Cat #:15070063) antibiotic.  
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2.5.2 UV crosslinking and harvesting of Hek 293T cells  
Transfected cells were washed twice with 10mL of PBS to remove cellular debris. 
Two PBS washed 15cm plates were then placed into a UV cross-linker (Spectrolinker 
XL-1500) on a tray of ice. Plates were exposed to 1000mJ/cm2 of UV radiation to 
covalently link all nucleic acids residues in direct or close contact with amino acid 
protein domains. Cross-linked cells were then resuspended in 3mL of RIPA buffer 
(50mM Tris PH 7.4, 150mM NaCl, 1% NP40, 1% Sodium deoxycholate, 0.01% SDS, 
protease inhibitor 1:1000 final, supeRNase inhibitor 1:1000 final) and aliquoted into 
1.5mL microfuge tubes. Tubes were spun down at 4°C at maximum speed for 2 minutes 
to pellet cells. The supernatant was removed and cell pellets were stored at -80°C until 
immunoprecipitation. 
 
2.5.3 Protein G bead preparation 
 Magnetic protein G Dynabeads (Thermoscientific Cat #: 10003D) were used for 
immunoprecipitation of GFP and C-myc-tagged proteins. For each sample, 65µL of 
protein G Dynabeads were washed twice with 400µL of RIPA buffer. Beads were then 
resuspended in 150µL of RIPA buffer and incubated with 10µg of GFP (Abcam Cat #: 
ab1218) or C-myc antibody (Abcam Cat #: ab32). As a negative control, 10µg of a 
human IgG control antibody (Thermoscientific Cat #: 31154) was used. The bead-
antibody solutions were left to rotate at room temperature for 60 minutes to allow for the 
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interaction between the respective antibodies and protein G beads to occur. Beads 
were then washed 3 times with RIPA buffer prior to immunoprecipitation. 
 
2.5.4 Cell lysis and partial RNA digestion 
 Hek 293T cell pellets where thawed on ice and later resuspended in 150µL of 
RIPA buffer. Cells transfected with the same vector where then pooled together into a 
single 1.5mL microfuge tube. To eliminate nucleic acid residues not bound to protein, 
15µL of RNase I (Ambion Cat#: AM2295) diluted to 1:500 along will 2µL of turbo DNase 
(Ambion Cat#: 1340) were added to the resuspended cells. Samples were placed in a 
37°C shaker for 4 minutes before immediately transferring them back onto ice. These 
samples were then spun at max speed (Eppendorf 5430R) for 45 minutes at 4°C and 
the supernatant collected for immunoprecipitation. Note: 10µL of this lysate was 
collected for western blot analysis to ensure efficient transfection of the vectors 
expressing GFP and C-myc tagged proteins.  
 
2.5.5 Immunoprecipitation of GFP and C-myc tagged proteins 
 The cell lysate for each sample obtained from the previous step was equally 
distributed into two parts. The first half was added to beads containing control IgG 
antibody while the second half was added to the beads containing their respective 
antibody (GFP for hLa, ΔNRE, 1-375 and C-myc for PABP). The beads were left to 
rotate with the cell lysate for 2 hours at 4°C. After 4°C incubation, supernatant was 
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discarded and the beads were washed twice with high salt RIPA buffer (500mM of NaCl 
instead of 150mM) and twice with Proteinase K (PNK) wash buffer (100mM Tris PH 7.6, 
500mM NaCl, 10mM EDTA). Prior to PNK treatment, 10µL of each sample was stored 
for western blot analysis to examine immunoprecipitation efficiency of GFP and C-myc 
tagged proteins. To remove all protein present in the IP samples, 200µL of PNK buffer 
along with 10µL of PNK were added and samples were placed at 37°C to incubate for 
20 minutes. After incubation, 200µL of PNK urea buffer (PNK buffer + 0.7M urea) was 
added to each sample along with 10µL of PNK and incubated at 37°C for 20 minutes. 
To extract the immunoprecipitated RNA for northern blot analysis, 400µL of acid phenol 
(Sigma Cat #:) was added to each sample and vortexed for 5 seconds to mix 
thoroughly. Samples were then spun at max speed for 10 minutes at 4°C. The top 
aqueous layer was collected into a new microfuge tube where 400µL of chloroform 
(Bioshop Cat #:) was added. Samples were spun at max speed for 10 minutes at 4°C. 
The top aqueous layer was collected into a new microfuge tube and precipitated by 
adding 1/10th the aqueous layer volume of 3M sodium acetate (ie: 40µL for 400µL of 
aqueous layer), 2.5 times aqueous layer volume with 100% etOH and 2µL of glycogen 
or glycoblue to aid in RNA pellet visualization. Samples were stored at -20°C over night. 
 
2.5.6 Northern blot analysis of immunoprecipitated RNA 
 Precipitated RNA samples were spun down for 10 minutes at max speed at 4°C. 
The 100% ethanol was removed and the pellets were washed by adding 70% ethanol 
and spinning again at maximum speed for 10 minutes at 4°C. The 70% ethanol was 
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removed and the RNA pellets were left to air dry at room temperature for 4 minutes. The 
RNA pellets were then resuspended in 10µL of formamide dye and heated at 95°C for 
10 minutes. In order to determine the size of bands seen on our membrane, 2µL of a 
radioactively labelled decade marker (Ambion Cat #: AM7778) was also mixed with 
10µL of formamide dye and heated at 95°C for 10 minutes. Note: this marker was 
radioactively labeled using γ-32P ATP following the protocol in 2.3.1 and gel extracted 
via 2.3.3.   During this incubation a pre-made 12% urea gel was set up and allowed to 
pre-run for 20 minutes at 100V at 4°C. Prior to loading, any urea buildup with in the 
wells due to pre-running were cleared. The gel was left to run at 100V at 4°C for ~2 
hours or until the bromophenol blue dye ran off the gel. After gel electrophoresis was 
completed, the samples were transferred onto a gene screen membrane (Perkin Elmer 
Cat #: NEF 1017001 PK) for northern blot analysis using the Invitrogen iBlot transfer 
system (Invitrogen Cat #: IB301002). After the 6-minute transfer, the membrane was 
crosslinked for 90 seconds (Fotodyne DNA transfer lamp) followed by drying for 10 
minutes at 80°C (BioRad model 583). The membrane was then incubated for 2 hours 
with pre-hybe buffer (6X SSC, 2X Denhardt’s solution (Thermo Scientific Cat #: 
750018), 1% SDS, 200µL of total yeast RNA 10mg/mL (Thermo Scientific Cat #: 
AM7118), 20 mL final volume) in a rotating hybridization oven (Tek Star Jr). Note: If 
probing with dt40, the temperature was set to 32°C however, if probing with human Met 
tRNA the temperature was set to 37°C. The probe (radioactively labelled using the 
protocol from 2.3.1) was heated at 95°C for 5 minutes before being adding to the 
membrane submerged in the pre-hybe buffer. Hybridization of the labelled probe to the 
membrane was allowed to proceed overnight in a rotating hybridization oven. The next 
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morning, northern blots were washed 3 times for 20 minutes with wash buffer (2X SSC, 
0.1% SDS) and then placed into an autoradiography cassette and left to expose on a 
storage phosphor-screen overnight. The screen was then scanned using a phosphor-
imager (GE typhoon scanner) to visualize the radioactive probe. For sequential probing 
the membrane was stripped (0.1X SSC, 0.1% SDS) 3 times for 20 minutes at 70°C. 
Repeat methodology from pre-hybridization step to examine hybridization with 
additional probes.      
 
2.5.7 Western blot analysis to check for transfection and           
immunoprecipitation efficiency 
 
 The 10µL of cell lysate obtained in 2.5.4 and immunoprecipitated samples in 
2.5.5 were subject to western blot analysis to examine transfection efficiency of GFP 
and C-myc expressing vectors in Hek 293T cells as well as their respective 
Immunoprecipitation efficiency from anti-GFP and anti-C-myc linked protein G beads. 
Samples were mixed with 3µL of loading dye (30µL of 5x Laemmli, 3µL 2-beta 
mercaptoethanol) and heated at 95°C for 8 minutes before being loaded onto a 10% 
SDS PAGE gel. Transfection and IP samples were run at room temperature for 90 
minutes at 125V. After SDS-PAGE, samples were transferred for 90 minutes at 50V 
onto a nitrocellulose membrane using transfer buffer (25mM Tris base, 190mM glycine) 
as the running buffer. The membrane was ponceau stained afterwards to check for the 
successful transfer of proteins and blocked overnight at 4°C using blocking buffer (1X 
TBS, 0.1% Tween, 3% skim milk). After blocking, the membrane was washed 3 times 
using 1X TBST buffer (1X TBS, 0.1%Tween) for 10 minutes followed by incubation with 
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primary antibody (1X TBST + 1/5000 dilution of anti GFP and C-myc antibody.) for 1 
hour. The membrane was then washed 3 times with 1X TBST for 10 minutes and 
incubated with secondary antibody (1X TBST + 1/2000 dilution of goat anti-mouse IgG) 
for 1 hour. After secondary, a final wash with 1X TBST was completed, followed by the 
incubation with ECL for 2 minutes (Thermo Scientific Cat #: 32106). The western blot 
was developed using autoradiography film to confirm the transfection of GFP and c-myc 
expressing vectors in Hek 293T cells as well as the successful immunoprecipitation of 
protein-RNA complexes with anti-GFP and anti-c-myc linked protein G beads. 
 
2.6 Immunoprecipitation of GFP-tagged proteins for mass    
spectrometry analysis 
 
2.6.1 Transfection of GFP-tagged proteins into Hek 293T cells 
 Hek 293T cells grown to 75% confluency were transfected with 12µg of empty 
GFP vector along with GFP vectors expressing hLa and hLa-ΔNRE. To obtain a 
sufficient yield of cells for downstream applications, two 15cm plates of cells were 
grown per sample. Transfection was completed by added 12µg of vector DNA to one 
set of 1.5mL microfuge tubes containing 400µL of 1X DMEM and 30µL of polyjet 
(Frogga bio Cat #: SL100688) to a second set of microfuge tubes containing the same 
amount of media. After a 2 minute incubation, contents from the second set of tubes 
were added to the first set of tubes containing media and vector DNA. To allow for 
polyjet-vector DNA complexes to form, the solutions were left to incubate at room 
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temperature for 15 minutes. During this incubation, cells were washed once with 10mL 
of pre-warmed PBS and refed with 14mL of fresh media (10% FBS, 1X DMEM). The 
polyjet-DNA containing solutions were then added to the 15cm dishes and left to 
incubate at 37°C. After 5 hours, cells were refed with fresh media containing pen strep 
(Gibco Cat #:15070063) antibiotic.  
 
2.6.2 Protein G bead preparation 
 Magnetic protein G Dynabeads (Thermoscientific Cat #: 10003D) were used for 
the immunoprecipitation of GFP tagged hLa, hLa-ΔNRE and an empty GFP control. For 
each sample, 65µL of protein G Dynabeads were added to 500µL of PBS with 0.1% 
tween. Next, 6µg of GFP primary antibody (Abcam Cat #: ab1218) was added to each 
sample and left to rotate overnight at 4°C. Note: bead preparation must be completed 
the night before making cell lysate.  
 
2.6.3 Cell Lysis and Immunoprecipitation 
 Transfected cells were washed twice with 10mL of PBS to remove cellular debris 
and resuspended in 3mL. These resuspended samples were transferred over to 1.5mL 
microfuge tubes and centrifuged at maximum speed for 2 minutes to pellet cells and 
discard PBS supernatant. Cell pellets were resuspended into 5 volumes of NP-40 lysis 
buffer (50mM Tris-HCl PH 7.6, 150mM NaCl, 0.5% NP-40, 2mM EDTA, 100mM NaF, 
10X Protease inhibitor cocktail (100µL aliquot/ 5mL of buffer)) and vortexed for 30 
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seconds every 10 minutes for 40 minutes. Note: keep samples on ice whenever 
possible. After cell lysis, spin down samples at 4°C for 10 minutes at maximum speed. 
Collect the supernatant as protein lysate. Before adding your lysate to the prepared 
protein G beads, wash twice with 400µL of PBS. Add up to 1mL of protein lysate to the 
beads and rotate samples overnight at 4°C. 
 
2.6.4 Protein elution and buffer exchange 
 After overnight incubation at 4°C, beads were washed once with 500µL of NP-40 
lysis buffer and twice with 500µL of NP-40 free lysis buffer (ddH2O replaces NP-40 in 
buffer). Elute Protein-protein complexes from the beads by adding 500µL of 0.5M NaOH 
to each sample, rotate at room temperature for 20 minutes. Spin samples down for 2 
minutes at 6000 RPM to pellet beads and collect supernatant into a 5mL concentrator 
conical (Amicon Ultra, 10 kDa). Fill up the concentrator with 50µM ammonium 
bicarbonate and spin at 5000RPM for 20 minutes at 4°C. Discard the flow through 
obtained in the collecting tube and repeat the process by refilling the conical tube with 
50µM ammonium bicarbonate and concentrating the sample down to ~100µL. Collect 
the buffer exchanged samples into a new 1.5mL microfuge tube and store at -80°C until 
mass spectrometry analysis. 
 
 
 
45 
 
 
RESULTS 
 
3.1 Proteins and radioactively labelled RNAs selected for EMSA analysis 
To investigate any observable differences between how hLa and the binding 
modes of its various mutated forms change in vitro, four RNA substrates were labelled 
using 32P ATP for EMSA analysis. A U20 oligomer was first used to test for differences 
in hLa’s terminal 3’ UUU-OH binding mode however, it was later decided that a U10 
oligomer more accurately addresses this. An A20 oligomer was used to examine 
differences in the poly-A binding mode and a CGC ala pre-tRNA was used to observe 
differences in the tRNA binding mode (which encompasses the 3’UUU-OH binding 
mode). hLa, hLa-ΔNRE and “double mutant” proteins were used for analysis. The 
“double mutant” ΔNRE E132A D133A contains a secondary mutation in the RRM1 
along with the removal of the NRE that has been shown to restore nuclear localization. 
Along with these mutants, a pair of substitution mutants were created based on the salt 
bridge interaction that is hypothesized between the glutamate and aspartate residues at 
positions 132 and 133 of the RRM1 respectively and the lysine residues at positions 
316 and 317 of the NRE. Substitution of these lysine residues to glutamate residues 
breaks this salt bridge interaction generating a mutant (hLa K316E K317E) that contains 
a similar cytoplasmic phenotype seen with the ΔNRE mutant. In an attempt to fix this 
salt bridge interaction, the glutamate and aspartate residues at positions 132 and 133 
were changed to lysine residues with the hopes that this “swapped mutant” hLa E132K 
D133K K316E K317E would be able to restore the binding activity that more resembles 
46 
 
 
wildtype hLa. The diagram in Figure 7 shows the various mutants created for EMSA 
analysis. 
 
 
 
 
 
Figure 7: The various proteins used for EMSA analysis. The double mutant ΔNRE E132A 
D133A not only lacks the NRE region, but contains additional substitution mutations in the 
RRM1 domain. hLa K316E K317E contains substitution mutations in the RRM1 while the hLa 
E132K D133K K316E K317E contains substitution mutations in both RRM1 and NRE 
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3.2 ΔNRE and ΔNRE E132A D133A mutants show a reduction in affinity for U20 
but not U10 binding upon comparison with hLa. 
 
Figure 8 A-C displays the gel shift results for U20 binding with wildtype hLa, its 
ΔNRE mutant, and the ΔNRE E132A D133A double mutant. In comparison with 
wildtype (Kd: 220nM), the ΔNRE mutant exhibits a substantial reduction in its affinity for 
the poly U substrate (Kd: 620nM). Wildtype La shows initial binding to its U20 target at 
250nM and complete binding by 500nM (8A). The ΔNRE mutant begins its binding at 
500nM and achieves complete binding by 1000nM (8B). Quantification of these EMSAs 
were completed and binding curves created using prism (8D). The rightward shift seen 
by ΔNRE (blue line) in the binding curve confirms the drop in poly U affinity. The double 
mutant also shows a reduction in U20 affinity (Kd: 921nM) as seen by both the gel shift 
in 8C and the binding curve 8D. The issue with using a U20 oligomer to examine hLa’s 
3’ UUU-OH binding mode is that this 20-mer of U’s is sufficiently long enough to make 
additional contacts with the protein outside of the La module binding pocket known for 
binding these sequences. Therefore, the binding differences seen between hLa and 
ΔNRE mutants could mean: 1) an important role for NRE in 3’ UUU-OH binding mode 
(which has not been shown in the literature to date) or 2) the U20 oligomer is making 
additional contacts with the CTD to strengthen its interaction with hLa that is not 
possible with ΔNRE mutants thus resulting in their differences of affinity.    
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To examine this, a U10 oligomer was used to test for 3’ UUU-OH dependant 
binding. This 10-mer is not long enough to make any additional contacts outside of the 
La module and therefore serves as a more accurate means of examining hLa’s terminal 
uridylate binding mode. Figure 9 A-C shows the EMSAs for hLa, ΔNRE and the ΔNRE 
E132A D133A double binding to the U10 oligo respectively. Using U10 as an RNA 
substrate instead of U20, the substantial differences in affinity originally seen between 
hLa and the ΔNRE mutants were eliminated (Kd values of 451nM and 676nM 
respectively). In addition, the nearly identical binding curves of all three proteins in 
figure 9D illustrates this no-change. Collectively these data suggest that the NRE plays 
no direct role in La’s 3’UUU-OH binding however; if poly U sequences are sufficiently 
long enough (greater then 10), they could potentially interact with this region increasing 
the protein’s affinity for this substrate.  
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  Figure 8: (A-C) EMSA results displaying wild type hLa, hLa-ΔNRE and the ΔNRE 
E132A D133A double mutant binding with a radioactively labelled U20 substrate. A drop 
in affinity for the U20 oligomer is observed between wildtype (Kd: 220nM) and ΔNRE 
(Kd: 620nM) followed by a subsequent reduction when comparing wildtype hLa with the 
double mutant (Kd: 921nM). (D) Binding curve highlighting the percentage of bound 
protein over increasing concentrations. The rightward shifts associated with ΔNRE 
(blue) and double mutants (red) illustrate their drop in affinity for the U20 oligomer. 
 
   
 
 
Kd: 220nM Kd: 620nM 
Kd: 921nM 
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  Figure 9: (A-C) EMSA results displaying wild type hLa, hLa-ΔNRE and the ΔNRE 
E132A D133A double mutant binding with a radioactively labelled U10 substrate. No 
substantial changes in substrate binding affinity are witnessed between proteins. (D) 
Binding curve highlighting the percentage of bound protein over increasing 
concentrations.  
 
 
 
 
 
 
Kd: 451nM Kd: 676nM 
Kd:706nM 
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3.3 hLa’s poly A binding mode is unaffected by the removal of its nuclear 
retention element. 
 
The gel shifts depicted in Figure 10 A-C show hLa, ΔNRE and the double mutant 
binding to an A20 oligomer to assess La’s poly A binding mode. Removal of La’s NRE 
region results in no drop in A20 affinity (Kd: 800nM) when compared to wildtype (Kd: 
722nM). Furthermore, the double mutant shows no notable change in A20 affinity (Kd: 
954nM) in comparison to wild type. The similarities of Kd values amongst the proteins is 
evident upon examination the EMSAs. All three proteins show to interact with the A20 
oligomer at 1000nM with hLa showing a glimpse of binding at 500nM. In addition, the 
binding curve in figure 10D illustrates the near identical A20 binding affinity seen with all 
three proteins. These findings suggest that La’s nuclear retention element has no 
importance in it’s poly A binding mode since its removal results in no change in poly A 
binding affinity. 
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Figure 10: (A-C) EMSA results displaying wild type hLa, hLa-ΔNRE and the ΔNRE 
E132A D133A double mutant binding with a radioactively labelled A20 substrate. No 
change in substrate affinity is observed. All proteins commence binding with the A20 
target at 1000nM. (D) Binding curve highlighting the percentage of bound protein over 
increasing concentrations.  
 
 
 
 
Kd: 722nM Kd: 800nM 
Kd: 954nM 
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3.4 ΔNRE and ΔNRE E132A D133A show a reduction in affinity for CGC pre-tRNA 
binding 
 
hLa’s pre-tRNA binding mode was examined in the gel shifts displayed in figures 
11 A-C. In comparison to wildtype (Kd: 144nM), the ΔNRE mutant shows nearly a four-
fold reduction in pre-tRNA affinity (535nM). At 250nM, wildtype hLa is shown to be 
completely bound to the pre-tRNA target (11A). This is evident from the lack of free 
RNA seen in the gel at this concentration. The ΔNRE mutant requires a concentration of 
1000nM to achieve this similar leveling of complete binding (11B). The ΔNRE mutant’s 
pre-tRNA affinity reduction is also illustrated by the rightward shift depicted in the 
binding curve of figure 11D. Surprisingly, the double mutant displays an even further 
reduction in pre-tRNA affinity (829nM) in comparison to the ΔNRE mutant with complete 
pre-tRNA binding achieved at 2000nM (11C). It is clear from these data that La’s NRE is 
important for maintaining its ability to efficiently bind to precursor tRNAs. Its removal 
results in a sharp decline in substrate affinity, which is indicated from the dramatic 
increases in CGC Kd values for hLa-ΔNRE and double mutants. The lack of any 
reduction in poly A affinity seen with ΔNRE mutants in Figure 10B in conjunction with 
the reduction in pre-tRNA affinity observed from these EMSAs lead us to question what 
happens when ΔNRE mutants are exposed to multiple RNA targets at once? In the 
presence of multiple RNA targets (an event which would normally occur within the 
nucleus) do these ΔNRE mutants maintain their engagement with precursor tRNAs or 
does the reduction in affinity now make them more susceptible to interaction with poly A 
tails of lesser characterized mRNA targets? This question is examined through 
competition EMSAs presented in section 3.8.  
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Figure 11: (A-C) EMSA results displaying wild type hLa, hLa-ΔNRE and the ΔNRE 
E132A D133A double mutant binding with a radioactively labelled CGC pre-tRNA 
substrate. A significant reduction in pre-tRNA affinity is witnessed with both hLa-ΔNRE 
and the ΔNRE double mutant with complete binding of the RNA substrate occurring at 
1000nM and 2000nM respectively; compared to wildtype which binds completely at 
250nM. (D) Protein binding curves highlighting the percentage of bound protein over 
increasing concentrations. The rightward shift seen in the ΔNRE (blue) and double 
mutant (red) binding curves illustrate this reduction in precursor tRNA affinity. 
Kd: 144nM Kd: 535nM 
Kd: 829nM 
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3.5 Disruption of hLa’s salt bridge with the K316E K317E mutant causes no 
change in its affinity for the U10 oligomer  
 
EMSAs were conducted on the salt bridge disrupting hLa K316E K317E mutant 
as well as the double swapped hLa E132K D133K K316E K317E mutant to examine the 
importance this NRE-RRM1 interaction may have on hLa’s 3’ terminal uridylate binding 
mode. U10 affinity does not seem falter upon disruption of this salt bridge interaction 
between the two domains. Both hLa and the K316E K317E mutant display similarities in 
U10 affinity with Kd values of 451nM and 474nM respectively (Figure 12 A-B). The 
substantial overlapping of the hLa binding curve (green) and the K316E K317E curve 
(blue) in figure 12D indicates the near identical binding affinity both proteins share for 
U10. Moreover, restoration of this inter-domain interaction with the double swapped 
mutant yields similar affinity to the U10 target (Kd: 539nM) as the aforementioned 
proteins (12C).  These findings suggest that the NRE-RRM1 inter-domain interaction is 
not required for hLa to recognize and bind to 3’ UUU-OH sequences; since the 
disruption and subsequent restoration of this inter-domain interaction with point mutants 
shows no difference in U10 affinity (as indicated by the similarities in Kd values). 
 
 
 
 
 
 
 
 
56 
 
 
 
 
 
Figure 12: (A-C) EMSA results displaying wild type hLa, hLa K316E K317E and the 
double swapped hLa E132K D133K K316E K317E mutant binding with a radioactively 
labelled U10 substrate. No substantial change in substrate binding affinity was observed 
amongst proteins. (D) Protein binding curve highlighting the percentage of bound 
protein over increasing concentrations. The overlapping of binding curves illustrates the 
similarities in U10 binding between proteins. 
 
 
 
 
 
Kd: 451nM Kd: 474nM 
Kd: 539nM 
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3.6 Disruption of hLa’s salt bridge with the K316E K317E mutant causes no 
change in its affinity for the A20 oligomer  
 
The hLa K316E K317E mutant shows minimal reduction in its affinity for the A20 
oligomer (Kd: 869nM) in comparison to wildtype (Kd: 722nM) as shown in figures 13A-
B. Moreover, the double swapped mutant (E132K D133K K316E K317E) also shows no 
change in affinity (Kd: 732nM) as depicted in figure 13C. The similarities of Kd values 
amongst the proteins is evident upon examination the EMSAs. All three proteins engage 
with the A20 oligomer at 1000nM and the nearly superimposable binding curves of each 
protein in figure 13D illustrates this similarity in A20 binding affinity. EMSA data from 
figure 10 concluded that elimination of hLa’s nuclear retention element causes no 
disruption of its poly A binding mode. Thus, it isn’t of much surprise that the ΔNRE-
mimicking K316E K317E mutant also shows no disruption of its poly A binding mode. 
The results from this set of EMSAs confirm the notion that hLa’s poly A binding mode 
remains unaffected upon 1) deletion of its NRE region or 2) the disruption of its salt 
bridge between NRE and RRM1 domains.  
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Figure 13: (A-C) EMSA results displaying wild type hLa, hLa K316E K317E and the 
double swapped hLa E132K D133K K316E K317E mutant binding with a radioactively 
labelled A20 substrate. No substantial changes to A20 affinity are witnessed between 
the examined proteins with target binding beginning at 1000nM. (D)Protein binding 
curve highlighting the percentage of bound protein over increasing concentrations. The 
nearly superimposable binding curves highlight the similarities in A20 target affinity. 
 
 
 
Kd: 722nM Kd: 869nM 
Kd: 732nM 
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3.7 Disruption of hLa’s salt bridge with the K316E K317E mutant exhibits a 
reduction in pre-tRNA affinity that can be partially restored by the E132K 
D133K K316E K317E mutant 
 
Disruption of hLa’s salt bridge interaction with the K316E K317E mutant resulted 
in a greater than four-fold reduction in pre-tRNA affinity (Kd: 695nM) compared to 
wildtype (Kd: 144nM). The EMSAs in figure 14 show wild type hLa completely bound 
to the pre-tRNA substrate at 250nM (14A) whereas the K316E K317E mutant reaches 
this same level of binding at 1000nM (14B). These findings suggest that the NRE-
RRM1 salt bridge may play an important role in pre-tRNA binding since its disruption 
results in a dramatic reduction in precursor tRNA affinity. In figure 14C, the double 
substitution mutant hLa E132K D133K K316E K317E shows the ability to restore pre-
tRNA binding by almost two-fold (Kd: 412nM). At 500nM, this mutant is almost 
completely bound to the RNA substrate. The results from this EMSA data set indicate 
that the K316E K317E mutant may interact with pre-tRNAs in a similar manner as the 
ΔNRE mutant since both show a similar reduction in pre-tRNA affinity. Furthermore, it 
would seem from the slight restoration of pre-tRNA binding, the attempts to fix the 
disrupted salt bridge interaction with the double substitution mutant may have been 
successful. Full restoration of pre-tRNA binding to the level of wildtype hLa is not seen 
however, improvement from the K316E K317E mutant is clearly evident. 
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Figure 14: (A-C) EMSA results displaying wild type hLa, hLa K316E K317E and the 
double swapped hLa E132K D133K K316E K317E mutant binding with a radioactively 
labelled pre-tRNA CGC alanine. Disruption of the hypothesized NRE-RRM1 salt bridge 
interaction with the K316E K317E mutant causes a 4-fold reduction in precursor tRNA 
affinity with binding now occurring at 1000nM rather then 250nM seen with wildtype. 
Attempts to restore this inter-domain interaction by switching the domain locations of the 
acidic and basic residues resulted in a 2-fold restoration with precursor tRNA binding 
now occurring at 500nM. (D) Binding curve highlighting the percentage of bound protein 
over increasing concentrations.  
61 
 
 
3.8 Poly U RNA competitor successfully competes off labelled A20 for binding in 
ΔNRE and hLa K316E K317E mutants 
 
Competition EMSA analysis was conducted to discover how hLa, ΔNRE and the 
salt bridge mutants behave upon simultaneous exposure to multiple RNA targets.  The 
competition EMSA was set up as followed; Radioactively labelled A20 was used to 
visualize the interaction with 2uM of protein. Cold U10 and A20 oligomers were added 
in increasing amounts to examine whether they could compete off the labelled A20 
oligo. Cold U10 was added in increasing amounts (0.5-32uM) in Figures 15A-C lanes 4 
to 1. The same increasing amounts of cold A20 were added in lanes 7 through 10 and 
acted as a positive control for RNA binding competition. No protein or competitor were 
added to lane 5 (NP lane) of the competition EMSA while strictly no competitor was 
added to lane 6 (NC lane). For all four proteins examined, an increase in the amount of 
free labelled A20 (seen at the bottom of the gels in lanes 7-10) upon increasing 
amounts of cold A20 suggests successful competition. The cold A20 oligo competes off 
the hot A20 oligomer because both bind to the same region on the protein. In figure 
15A, the addition of cold U10 in increasing amounts (lanes 4-1) to hLa results in no 
visible change to A20 binding. From this, it appears that wildtype hLa is locked into a 
conformation that enables it to bind to poly A’s however this conformation does not 
seem compatible for recognizing 3’ UUU-OH sequences. Conversely, when observing 
the ΔNRE mutant in figure 15B it is evident that A20 begins to get competed off by cold 
U10 starting at 2uM and increasing as the concentration of U10 increases to 32uM. 
Such a result would suggest the notion that U10 and A20 are now competing for the 
same binding site with the elimination of the NRE. The hLa K316E K317E mutant in 
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figure 15C also displays similar behaviour with addition of cold U10 competing off the 
radioactively labelled A20. This suggests that the NRE-RRM1 salt bridge may play an 
important role in controlling hLa’s distinct binding modes (either A binding or U binding-
not both) and therefore its removal makes the protein more accessible for competition 
between multiple RNA targets. The double substitution mutant hLa E132K D133K 
K316E K317E (15D) does not seem to completely restore wildtype behaviour since a 
small portion of labelled A20 is competed off by increasing amounts of cold U10 
however, this competition is not as substantial as that seen with the K316E K317E 
mutant.  The EMSAs in figure 15 A-D were quantified using prism graph pad and the 
percentage of labelled A20 bound to the proteins was plotted against the increasing 
concentrations of cold U10 added (Figure 16). The slope of each curve (obtained from 
the graphing software) indicates the rate of competition between the RNA targets for 
each protein and are summarized in table 4. Wild type hLa and the double swapped 
mutant displayed the least amount of competition from the EMSA data and therefore 
possessed flatter binding curves which corresponds to smaller or “less negative” slopes. 
In contrary, ΔNRE and hLa K316E K317E showed a larger amount of competition which 
upon quantification, was illustrated by their steep binding curves and corresponded with 
larger or “more negative” slopes. These binding curve data provide quantitative values 
to support the qualitative results seen with the competition EMSAs.        
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Figure 15: (A-D) Competition EMSA analysis. 2uM of protein shifting radioactively 
labeled A20 with increasing amounts of cold U10 (Lanes 4-1) and A20 (Lanes 7-10) 
competitor. NP refers to no protein or competitor added while NC lanes contain 2uM of 
protein but no competitor. U10 displays competition of A20 with the ΔNRE and K316E 
K317E mutants but not with hLa. The double substitution mutant (D) seems to show 
competition for binding among the two RNAs but to a much lesser extent.  
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Figure 16: Percentage of A20 bound to protein plotted against increasing amounts of 
cold U10 competitor. Data points obtained through quantification of competition EMSAs 
in figure 15. Prism Graphpad was used to create the binding curves. 
 
 
 
Table 4: The average slope of each binding curve depicted in figure 16 is summarized 
in the table below. The average slope, taken from the first and last data point of each 
curve represents the average rate of competition for binding between U10 and A20 
targets. ΔNRE and K316E K317E mutants show the largest negative slope 
corresponding to the most competition between RNA targets. 
Protein  Slope of binding curve 
hLa -4.39x10-4  
ΔNRE -1.03x10-3  
hLa K316E K317E -1.69x10-3  
hLa E132K D133K K316E K317E -8.54x10-4  
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3.9 CLIP analysis suggests that ΔNRE mutants interact with a greater proportion 
of poly A substrates than tRNA substrates in vivo. 
 
Cross-linking immunoprecipitation (CLIP) was conducted to identify the 
abundance of poly A RNA substrates and tRNA substrates interacting with PABP, hLa, 
ΔNRE and a strictly cytoplasmic variant of hLa known as 1-375 which lacks its nuclear 
localization signal. Hek293T cells were transfected with either c-myc tagged PABP or 
GFP tagged hLa, ΔNRE or 1-375. After 24 hours of transfection cells were UV 
crosslinked and lysed. Appendix H shows the western blot conducted using a sample of 
each cell lysate. The presence of bands in all tagged protein lanes confirms successful 
transfection. Magnetic Dynabeads were incubated overnight with 6ug of anti c-myc and 
GFP antibodies prior to the addition of cell lysate. As a control, a separate set of beads 
were incubated with 6ug of a control IgG antibody. Half of the cell lysate sample was 
added to beads containing the appropriate antibody while the other half was added to 
the beads contain the control IgG. The western blot seen in Appendix I highlights the 
results of the immunoprecipitation. The size of the c-myc tagged PABP and GFP tagged 
hLa and mutant variants are approximately 65-70KDa. Bands of this relative size are 
seen in all + lanes which contain the appropriate c-myc or GFP antibody. This western 
confirms the successful pulldown of tagged proteins. Pulldown samples were then 
treated with proteinase K to eliminate all protein leaving only the interacting nucleic 
acids remaining. These samples were transferred onto a nitrocellulose membrane for 
northern blot analysis. Figure 17A shows the northern blot results using a dt40 probe 
which binds to all poly A containing RNA substrates. PABP served as a positive control 
for strictly poly A substrate binding while 1-375 was used to identify the abundance of 
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poly A substrates pulled down by a strictly cytoplasmic mutant. These two proteins 
show the greatest amount of poly A substrate pulldown (Figure 17 lanes 3 and 9) with 
PABP pulling down the largest amount of poly A substrates. Both hLa and ΔNRE 
mutants pull down poly A however nonspecific poly A pulldown is also seen in the 
control IgG antibody lanes (- lanes) of these proteins. Figure 17B shows the northern 
blot results using a Met tRNA probe. As expected, no tRNA substrates are pulled down 
with PABP. Moreover, a relatively equal amount of tRNAs are pulled down with hLa and 
ΔNRE which represent the most of the examined proteins while very little tRNAs are 
pulled down with the cytoplasmic mutant. Prior to quantification, the band intensities 
seen in all (+) lanes were subtracted by the intensity values obtained from their 
respective control (-) lane in order to normalize the data and eliminate the effect on non-
specific binding. After quantification, dt40 band intensity for each protein were divided 
by their respective Met tRNA intensity to obtain a ratio. These ratios represent the 
proportion of poly A substrates to tRNA substrates pulled down by each protein and 
were plotted on the bar graph in figure 18. PABP shows the highest dt40/Met tRNA ratio 
suggesting that these proteins pulled down a substantially greater amount of poly A 
RNAs to tRNAs. The second largest ratio is obtained by the 1-375 mutant. Considering 
this mutant is only present in the cytoplasm it exposure to poly A tails from mRNAs 
would far exceed exposure to Met tRNAs. Finally, ΔNRE mutants seems to have a 
larger dt40/Met tRNA ratio in comparison to wild type hLa. This may suggest that in 
vivo, ΔNRE mutants are interacting with poly A containing RNAs to a greater extent 
than tRNAs, specifically Met tRNAs. 
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Figure 17: Crosslinking immunoprecipitation northern blot probing for poly A sequences 
using dt40 (A) and human methionine tRNA (B). Hek293T cells transfected with either 
c-Myc tagged PABP or GFP-tagged hLa, ΔNRE or hLa 1-375 were UV crosslinked and 
immunoprecipitated with either control IgG antibody (- lanes) or their respective c-myc 
and GFP antibodies (+ lanes). 
 
 
 
Figure 18: Quantification of northern blot results seen in figure 17. All 
values were normalized by subtracting the intensities of the control (-) 
lanes from the (+) lanes. Normalized Met tRNA intensities were divided 
from dt40 values to obtain a ratio of poly A sequences to methionine 
tRNA sequences pulled down for each protein. 
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DISCUSSION 
 
4.1 hLa’s 3’ UUU-OH binding mode remains unaffected upon NRE deletion 
 
 The initial findings from the U20 EMSA data set suggesting a reduction in 3’ 
UUU-OH binding with hLa-ΔNRE raised suspicion as to whether this was truly a 
reduction in the U binding mode or if this was due to the fact that being sufficiently long 
enough, the U20 was making additional contacts on hLa that were not possible on the 
NRE lacking mutant. Examination of U10 binding addressed this problem and showed 
that no differences in affinity where now witnessed between hLa-ΔNRE and wildtype. 
Similar findings regarding U10 binding were also seen with hLa K316E K317E and the 
double substituted hLa E132K D133K K316E K317E when compared to wildtype. These 
data enable us to conclude that removal of the NRE nor the disruption of the NRE-
RRM1 salt bridge affects La’s 3’ UUU-OH recognition. Although these findings may 
appear as null results, they do help improve our understanding of how hLa engages 
with it’s 3’ UUU-OH containing RNA targets. Until now, published data has only showed 
hLa’s conserved NTD interacting with these targets 6; the solved crystal structure 
highlighting this interaction did not contain the protein’s CTD where the NRE is located. 
Our U10 EMSA data allows us to can expand on this current understanding by 
confirming that hLa’s NRE has no role in binding with 3’ terminal uridylate sequences.  
The limitation presented with using a poly U oligo for binding is that such 
sequences alone do not exist in nature. However, these sequences are found on the 
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ends of all pol III transcripts which hLa is known to bind to therefore, the use of a U10 
oligomer allowed us to examine this interaction in a simplified manner. 
4.2 Removal or mutation of hLa’s NRE homogenizes the poly A binding mode 
with its 3’UUU-OH binding 
 
Binding affinity for the A20 oligomer showed no change upon disruption of hLa’s 
NRE-RRM1 salt bridge or elimination of it’s NRE entirely. Compared to hLa’s 3’UUU-OH 
binding and precursor tRNA binding, the poly A binding mode is less characterized. 
Despite this, it is currently understood that the LAM, RRM1 and RRM2 all play a role in 
A20 binding since elimination or mutation to these domains results in a reduction in A20 
affinity (unpublished lab data). Therefore, it does not come as a complete surprise that 
elimination of the NRE or the mutations made to it (K316E K317E) resulted in no 
change in poly A affinity.  
In spite of this, hydrogen deuterium mass spectrometry analysis (H/D exchange) 
from a collaborating lab tells a different story. Using H/D exchange, our collaborators 
examined how the structural domains of hLa and hLa-ΔNRE change when bound to a 
U10 and A20 RNA substrate. They discovered that removal of the NRE helix causes 
these mutants to bind to A20 targets as if they were U10. This contrasted wildtype 
which displayed two separate H/D exchange patterns when bound to U10 and A20 
suggesting separate binding modes. These findings strongly suggest that elimination of 
the NRE results in a homogenization of hLa’s 3’UUU-OH binding mode and its poly A 
binding mode. Further H/D exchange analysis on hLa K316E K316E produced similar 
findings indicating a homogenization between said binding modes. Conversely, 
70 
 
 
examination of hLa E132K D133K K316E K317E generated two separate H/D 
exchange patterns similar to those seen with wildtype suggesting that restoration of the 
NRE-RRM1 salt bridge in turn restores this separation of binding modes. Interestingly, 
the findings from our collaborators can be used to explain the results observed from our 
competition EMSAs. Homogenization of the 3’UUU-OH binding mode with it’s poly A 
binding would make hLa-ΔNRE and hLa K316E K317A mutants more susceptible to 
competition when presented with U10 and A20 since these proteins would bind both 
targets the same way. The competition EMSA data supports this, with both hLa-ΔNRE 
and hLa K316E K317A mutants showing the greatest amount of competition between 
targets while wildtype and hLa E132K D133K K316E K317E show minimal to no 
competition.        
These data do however highlight a limitation with the usage of EMSAs to assess 
protein interaction. Although EMSAs provide us with differences in affinity for binding 
targets, they do not give detailed information as to how the protein is interacting with its 
target. Our EMSA data revealed no differences in A20 affinity between hLa and ΔNRE 
however the H/D exchange data from our collaborators shows that although affinity 
does not change, the way hLa-ΔNRE engages with these targets has. 
 
4.3 hLa’s NRE contains an indirect yet important role in precursor tRNA binding 
 The substantial differences in RNA target binding between hLa and  hLa-ΔNRE 
mutants were seen when examining the precursor tRNA binding mode. Deletion of the 
NRE resulted in a substantial drop in pre-tRNA affinity. Moreover, mutations made to 
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the NRE (K316E K317E) also resulted in a dramatic decrease in pre-tRNA affinity 
compared to wildtype. Our U10 EMSA data indicates that no changes to 3’UUU-OH 
binding exists between hLa and the mutants tested thus, it can be concluded that these 
differences in pre-tRNA binding are not due to deficiencies in binding the 3’ trailer of the 
pre-tRNA. These data suggest that hLa’s NRE either makes direct contact with the body 
of the pre-tRNA to stabilize the interaction or indirectly ensures the protein maintains a 
favourable conformation to bind pre-tRNAs. To date, only two other domains of hLa are 
known to make direct contact with the pre-tRNA aside from the La module binding the 3’ 
trailer sequence. The loop 3 region of the RRM1 comprised of amino acids 143-151 
directly interact with the body of the pre-tRNA while the SBM located directly after the 
NRE binds to the 5’ leader of the pre-tRNA with high affinity unless phosphorylated at 
serine 366. If NRE were to play a direct role in binding, its elimination or mutation 
should result in an irreversible loss of affinity for pre-tRNA substrates. However, this is 
not the case since pre-tRNA binding can be restored 2-fold in hLa K316E K317E 
mutants by changing the acidic residues in the RRM1 to basic lysine residues (hLa 
E132K D133K K316E K317E).  These findings suggest an indirect role played by the 
NRE; one that relies on contacts made between acidic residues of the RRM1 (132 and 
133) and basic lysine residues at positions 316 and 317 to promote a structural 
conformation that is favourable for pre-tRNA binding. The disruption of this inter-domain 
interaction either through point mutation to the NRE or its removal entirely causes a 
reduction in pre-tRNA binding affinity because the protein can no longer maintain a 
conformation that supports interaction with the body of the pre-tRNA. By switching the 
location of these charged residues but maintaining the potential for inter-domain 
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interaction, pre-tRNA binding affinity is partially restored. This emphasizes the indirect 
yet crucial role NRE possess; maintaining proper pre-tRNA binding through contains 
with the RRM1 so that subsequent processing can occur.   
4.4 Proposing a model for the inappropriate nuclear export of hLa-ΔNRE 
 The CLIP assay provided us with an in vivo approach to examine the type of 
RNAs interacting with hLa and hLa-ΔNRE. Results from this experiment indicated that 
hLa-ΔNRE mutants were immunoprecipitated with a greater proportion of poly A 
messages bound to them than tRNAs. Our pre-tRNA and A20 EMSA data can be used 
to provide an explanation for these results. A20 EMSA data revealed no changes in 
binding affinity between hLa and hLa-ΔNRE however it was discovered through H/D 
exchange data of our collaborators that hLa-ΔNRE mutants bind to poly A and poly U 
sequences identically. In addition to this newly generated competition for binding 
between poly A and U targets hLa-ΔNRE mutants also display a substantial reduction in 
pre-tRNA binding affinity in comparison with wildtype. Taken together, these data 
suggest that in the nucleus where proteins are exposed to an abundance of RNAs, hLa-
ΔNRE mutants may now be more susceptible to binding poly A messages since 1) 
these messages now compete for the same site as the 3’ trailer of pre-tRNAs and 2) 
pre-tRNA binding is notably reduced. The consequence for binding to the poly A tail of 
an mRNA target instead of a pre-tRNA is that these mutants are now inappropriately 
exported from the nucleus. The mechanism for export is crm1 dependant since 
inhibition via LMB restores the proteins nuclear phenotype. Thus it is hypothesized that 
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mRNAs exported in a crm1 dependant manner would be clear targets for hLa-ΔNRE 
binding.  
 This model does contain some limitations; one of which is that it can not be used 
to explain the nuclear restoration seen with ΔNRE E132A D133A double mutant in 
previous literature. A20 EMSA data shows no difference in affinity however H/D 
exchange analysis was not conducted on this mutant thus no additional information as 
to how this mutant may specifically interact with an A20 target is available. In addition, 
this mutant’s pre-tRNA binding displayed a greater drop in affinity compared to hLa-
ΔNRE. Therefore, using the rationale from the proposed model, this mutant should be 
cytoplasmic but in reality it is nuclear. Despite this, the proposed model attempts to 
provide a simplistic explanation for the cytoplasmic phenotype seen with hLa-ΔNRE that 
not only is supported by the EMSAs conducted but also by the CLIP data.  
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FUTURE PERSPECTIVES 
Due to the similarities in RNA binding behaviours of hLa-ΔNRE and hLa K316E 
K317E, it would be of interest to conduct a CLIP on cells overexpressing hLa K316E 
K317E as well as the double substitution mutant hLa E132K D133K K316E K317E. Due 
to their similarities in RNA target binding it would be hypothesized that cells expressing 
hLa K316E K317E immunoprecipitate with greater proportion of mRNAs bound to them 
than tRNAs, similar to what was observed with hLa-ΔNRE. In contrast, due to the 
restoration in RNA target affinity, it is hypothesized that hLa E132K D133K K316E 
K317E mutants would be able to restore RNA target preference back to what was 
witnessed with wildtype hLa. These experiments could be used to confirm the 
importance that the NRE-RRM1 inter-domain interaction has on maintaining pre-tRNA 
binding affinity in vivo as all current data used to propose this has been completed in-
vitro through EMSAs as well as H/D exchange analysis from our collaborators. 
 To address whether protein-protein interactions have a designated role in 
mediating hLa’s intracellular phenotype, Hek 293T cells overexpressing hLa and hLa-
ΔNRE were immunoprecipitated and these complexes sent for HPLC mass 
spectrometry analysis to identify any differences in the protein pulled down. 
Furthermore, additional samples were sent after RNAse treatment to eliminate any 
protein bound to hLa or hLa-ΔNRE that may be mediated through an RNA sequence. 
Unfortunately, we are still waiting on the results from said experiments from our 
collaborator therefore, no additional comments can be made at this point.        
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APPENDICES 
 
 
 
Appendix A: Calculating Protein Concentration 
 
Quantifying a protein using known BSA standards also you to determine a quantity of 
protein in µg/µL. This value can then be converted in µM concentration using the 
equation below: 
                                                               [Protein quantity in g/L]  
Protein Concentration in µM=           _________________________                     
 
                                                              48000g/mol (MW of hLa) 
 
 
 
Appendix B: Calculating Percentage of Protein Bound  
To generate a binding curve using Graphpad prism software a percent of protein bound 
was plotted against the respective protein concentration. The calculation performed to 
determine percent bound was: 
                                                                   RNA Bound 
                                                                  _________________________  x 100 
Percent protein bound =      (RNA Bound + RNA Unbound) 
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 Appendix C: SDS-PAGE of hLa stock dilutions compared against known BSA 
standards to estimate quantitiy of hLa present in stock. Samples were run on a 
10% gel at 120mV. 
 
 
 
Appendix D: SDS-PAGE of hLa-ΔNRE dilutions compared with known BSA 
standards to estimate quantity of hLa-ΔNRE in eluted stock. Samples were run on 
a 10% gel at 120mV. 
 
84 
 
 
 
 
Appendix E: SDS-PAGE of ΔNRE E132A D133A dilutions compared with 
known BSA standards to estimate quantity in eluted stock. Samples were run 
on a 10% gel at 120mV. 
 
 
 
 
Appendix F: SDS-PAGE of hLa K316E K317E dilutions compared with 
known BSA standards to estimate quantity of protein in eluted stock. 
Samples were run on a 10% gel at 120mV 
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Appendix G: SDS-PAGE of ΔNRE E132K D133K K316E K317E 
dilutions compared with known BSA standards to estimate quantity of 
hLa-ΔNRE in eluted stock. Samples were run on a 10% gel at 120mV. 
 
 
 
 
Appendix H: Western blot of the transfection of c-myc tagged 
PABP and GFP tagged hLa, NRE and 1-375 into Hek293T 
cells. 
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Appendix I: Western blot of the immunoprecipitation of c-myc 
tagged PABP and GFP tagged hLa, NRE and 1-375. 6ug of 
control IgG antibody incubated with lysate in (-) lanes and 6 ug of 
c-myc and GFP antibody incubated with lysate in (+) lanes.  
